Monday, March 20, 2006
Whistleblower may be aiding Investigation into Alleged Illegal Drug Promotion
The Seattle Times is reporting that a whistleblower may be aiding a government investigation into whether Cell Therapeutics, a Seattle pharmaceutical company, unlawfully promoted a drug for unapproved uses. In its annual report filed with the Securities and Exchange Commission last Thursday, Cell Therapeutics disclosed that a “private party” has made claims against it “under seal on behalf of the government,” according to the Seattle Times.
The federal False Claims Act enables private citizens to bring charges against private companies who have allegedly defrauded the government, and to claim part of any award against the company for their effort. Click the following link to read the story about the false claims investigation.
Posted by Quitam Help Admin on 03/20 at 03:45 PM
Page 1 of 1 pages
Printer Friendly Page